Asthma and HIV drug drive performance growth, GSK's Q1 profits exceed expectations, maintains full-year performance outlook.
According to the intelligent financial APP, British pharmaceutical giant GlaxoSmithKline (GSK.US) released its first quarter performance report on Wednesday local time. The financial data shows that the company's first quarter profit exceeded expectations, especially strong sales of asthma and HIV treatment drugs offset the negative impact of the overall sales performance of the vaccine business line falling short of expectations.
Latest